Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now
Equities

Tianjin TEDA Biomedical Engineering Co Ltd

8189:HKG.HZ

Tianjin TEDA Biomedical Engineering Co Ltd

Actions
  • Price (HKD)0.195
  • Today's Change0.00 / 0.00%
  • Shares traded415.00k
  • 1 Year change+129.41%
  • Beta--
Data delayed at least 15 minutes, as of Nov 01 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Tianjin TEDA Biomedical Engineering Company Limited is a China-based company principally engaged in the research and development, commercialization, manufacturing and sales of biological compound fertilizer products. Its primary products include the series of biological compound fertilizer products for the promotion of balanced growth of grains, fruits and vegetables. These products are mainly sold under the brand of Fulilong. The Company’s businesses are mainly conducted in the People’s Republic of China (the PRC). The Company’s principal subsidiaries include Shandong Hidersun Fertiliser Industry Co., Ltd. and Guangdong Fulilong Compound Fertiliser Co., Ltd.

  • Revenue in HKD (TTM)462.76m
  • Net income in HKD-8.12m
  • Incorporated2000
  • Employees264.00
  • Location
    Tianjin TEDA Biomedical Engineering Co Ltd9F, Block A2 Tianda High-tech Park No.80The 4th AvenueTianjin Eco and Tech Dev AreaTIANJIN 300457ChinaCHN
  • Phone+86 2 259816900
  • Fax+86 2 259816909
  • Websitehttp://www.bioteda.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.